Anti-HBV efficacy of combined siRNAs targeting viral gene and heat shock cognate 70

Virology Journal

Volumn 9, Issue , 2012, Pages

  Bian, Zhongqi ^a,b   Xiao, An ^a   Cao, Mingmei ^c   Liu, Mingqiu ^b   Liu, Shuang ^b   Jiao, Ye ^b   Yan, Weiyao ^b   Qi, Zhongtian ^c   Zheng, Zhaoxin ^b  

^a KUNMING GENERAL HOSPITAL   (China)

^b FUDAN UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Combinational RNAi; Heat shock cognate 70; Hepatitis B virus; RNA interference; Short hairpin RNA

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; ENHANCED GREEN FLUORESCENT PROTEIN; HEAT SHOCK PROTEIN 70; INTERFERON; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL STRAIN HEK293; CELL STRAIN HEPG2; CELL VIABILITY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE SILENCING; HEPATITIS B VIRUS; INNATE IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PLASMID; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SUPERNATANT; VIRUS GENE; VIRUS REPLICATION;

CELL LINE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; GREEN FLUORESCENT PROTEINS; HEP G2 CELLS; HEPATITIS B; HEPATITIS B VIRUS; HSC70 HEAT-SHOCK PROTEINS; HUMANS; PLASMIDS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; VIRAL PROTEINS; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 84869035204     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-275     Document Type: Article

References (72)

1. Hepatitis B virus infection. Lee WM, N Engl J Med 1997 337 1733 1745 (Pubitemid 27527771)
2. Global control of hepatitis B virus infection. Kao JH, Chen DS, Lancet Infect Dis 2002 2 395 403
3. Hepatitis B virus infection-natural history and clinical consequences. Ganem D, Prince AM, N Engl J Med 2004 350 1118 1129 (Pubitemid 38298992)
4. Hepatitis B virus infection. Liaw YF, Chu CM, Lancet 2009 373 582 592
5. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS, Int J Epidemiol 2005 34 1329 1339 (Pubitemid 41819540)
6. Chronic hepatitis B: update 2009. Lok AS, McMahon BJ, Hepatology 2009 50 661 662
7. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC, Nature 1998 391 806 811 (Pubitemid 28099681)
8. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Hammond SM, Bernstein E, Beach D, Hannon GJ, Nature 2000 404 293 296 (Pubitemid 30163547)
9. Argonaute2, a link between genetic and biochemical analyses of RNAi. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ, Science 2001 293 1146 1150 (Pubitemid 32758097)
10. On the road to reading the RNA-interference code. Siomi H, Siomi MC, Nature 2009 457 396 404
11. Current prospects for RNA interference-based therapies. Davidson BL, McCray PB, Nature Rev Genet 2011 12 329 340
12. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T, Nature 2001 411 494 498 (Pubitemid 32494397)
13. A system for stable expression of short interfering RNAs in mammalian cells. Brummelkamp TR, Bernards R, Agami R, Science 2002 296 550 553 (Pubitemid 34408678)
14. Modulation of HIV-1 replication by RNA interference. Jacque JM, Triques K, Stevenson M, Nature 2002 418 435 438 (Pubitemid 34826845)
15. siRNA-directed inhibition of HIV-1 infection. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee SK, Collman RG, Lieberman J, Shankar P, Sharp A, Nat Med 2002 8 681 686 (Pubitemid 34778720)
16. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Kumar P, Ban HS, Kim SS, Wu H, Pearson T, Greiner DL, Laouar A, Yao J, Haridas V, Habiro K, Yang YG, Jeong JH, Lee KY, Kim YH, Kim SW, Peipp M, Fey GH, Manjunath N, Shultz LD, Lee SK, Shankar P, Cell 2008 134 577 586
17. Inhibition of hepatitis B virus in mice by RNA interference. McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, Wieland SF, Marion PL, Kay MA, Nat Biotech 2003 21 639 644 (Pubitemid 36638090)
18. Inhibition of hepatitis B virus expression and replication by RNA interference. Shlomai A, Shaul Y, Hepatology 2003 37 764 770 (Pubitemid 36397386)
19. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W, Hartsough K, Machemer L, Radka S, Jadhav V, Vaish N, Zinnen S, Vargeese C, Bowman K, Shaffer CS, Jeffs LB, Judge A, MacLachlan I, Polisky B, Nat Biotechnol 2005 23 1002 1007 (Pubitemid 41114035)
20. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Uprichard SL, Boyd B, Althage A, Chisari FV, Proc Natl Acad Sci USA 2005 102 773 778 (Pubitemid 40282741)
21. 5'Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human Liver cells and mice. Ebert G, Poeck H, Lucifora J, Baschuk N, Esser K, Esposito I, Hartmann G, Protzer U, Gastroenterol 2011 141 696 706
22. RNA interference in adult mice. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA, Nature 2002 418 38 39 (Pubitemid 34742563)
23. Interference of hepatitis C virus RNA replication by short interfering RNAs. Kapadia SB, Brideau-Andersen A, Chisari FV, Proc Natl Acad Sci USA 2003 100 2014 2018 (Pubitemid 36254565)
24. Effective inhibition of hepatitis E virus replication in A549 cells and piglets by RNA interference (RNAi) targeting RNA-dependent RNA polymerase. Huang F, Hua X, Yang S, Yuan C, Zhang W, Antiviral Res 2009 83 274 281
25. Inhibition of influenza virus production in virus-infected mice by RNA interference. Ge Q, Filip L, Bai A, Nguyen T, Eisen HN, Chen J, Proc Natl Acad Sci USA 2004 101 8676 8681 (Pubitemid 38745830)
26. Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S. Akerstrom S, Mirazimi A, Tan YJ, Antiviral Res 2007 73 219 227
27. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference:a proof-of-concept study. Geisbert TW, Lee A, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, Jong S, Tavakoli I, Judge A, Hensley LE, MacLachlan I, Lancet 2010 375 1896 1905
28. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Judge AD, Sood V, Shaw JR, Fang D, McClintock K, MacLachlan I, Nat Biotechnol 2005 23 457 462 (Pubitemid 41724921)
29. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, Noronha A, Manoharan M, Akira S, de Fougerolles A, Endres S, Hartmann G, Nat Med 2005 11 263 270 (Pubitemid 40460553)
30. Induction of the interferon response by siRNA is cell type-and duplex length-dependent. Reynolds A, Anderson EM, Vermeulen A, Fedorov Y, Robinson K, Leake D, Karpilow J, Marshall WS, Khvorova A, RNA 2006 12 988 993 (Pubitemid 43788117)
31. Activation of the interferon system by short-interfering RNAs. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR, Nat Cell Biol 2003 5 834 839 (Pubitemid 37087172)
32. Special delivery: targeted therapy with small RNAs. Peer D, Lieberman J, Gene Ther 2011 18 1127 1133
33. Bian ZQ, Zheng ZX, RNA Interference molecular mechanism and preventive strategy against viruses Beijing: Scientific Publishers 1 2009
34. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA, Nature 2006 441 537 541 (Pubitemid 44050158)
35. Chaperone action in the posttranslational topological reorientation of the hepatitis B virus large envelope protein: implications for translocational regulation. Lambert C, Prange R, Proc Natl Acad Sci USA 2003 100 5199 5204 (Pubitemid 36542682)
36. Chaperones involved in hepatitis B virus morphogenesis. Prange R, Werr M, Loffler-Mary H, Biol Chem 1999 380 305 314 (Pubitemid 29145944)
37. The heat shock cognate protein 70 is associated with hepatitis C virus particles and modulates virus infectivity. Parent R, Qu X, Petit MA, Beretta L, Hepatology 2009 49 1798 1809
38. Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice. Nakagawa S, Umehara T, Matsuda C, Kuge S, Sudoh M, Kohara M, Biochem Biophys Res Commun 2007 353 882 888 (Pubitemid 46080379)
39. HSP70-2 heat-shock protein of mouse spermatogenic cells. Eddy EM, J Exp Zool 1998 282 261 271 (Pubitemid 28395526)
40. The peptide-binding and ATPase domains of recombinant hsc70 are required to interact with rotavirus and reduce its infectivity. Pérez-Vargas J, Romero P, López S, Arias CF, J Virol 2006 80 3322 3331
41. Efficient Hsp90-independent in vitro activation by Hsc70 and Hsp40 of duck hepatitis B virus reverse transcriptase, an assumed Hsp90 client protein. Beck J, Nassal M, J Biol Chem 2003 278 36128 36138 (Pubitemid 37139934)
42. Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function. Hu J, Flores D, Toft D, Wang X, Nguyen D, J Virol 2004 78 13122 13131 (Pubitemid 39507819)
43. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Herker E, Harris C, Hernandez C, Carpentier A, Kaehlcke K, Rosenberg AR, Farese RV Jr, Ott M, Nature Med 2010 16 1295 1298
44. Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A. Chen YC, Su WC, Huang JY, Chao TC, Jeng KS, Machida K, Lai MM, J Virol 2010 84 7983 7993
45. Two-dimensional blue native/SDS-PAGE analysis reveals heat shock protein chaperone machinery involved in hepatitis B virus production in HepG2.2.15 Cells. Liu K, Qian L, Wang JL, Li WR, Deng XY, Chen XL, Sun W, Wei HD, Qian XH, Jiang Y, He FC, Mol Cell Proteomics 2009 8 495 505
46. Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus. Wang YP, Liu F, He HW, Han YX, Peng ZG, Li BW, You XF, Song DQ, Li ZR, Yu LY, Cen S, Hong B, Sun CH, Zhao LX, Kreiswirth B, Perlin D, Shao RG, Jiang JD, Antimicrob Agents Chemother 2010 54 2070 2077
47. Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster. Yang X, Haurigot V, Zhou S, Luo G, Couto LB, Hepatology 2010 52 1877 1887
48. Optimization of linear double-stranded RNA for the production of multiple siRNAs targeting hepatitis C virus. Shin D, Lee H, Kim SI, Yoon Y, Kim M, RNA 2009 15 898 910
49. Combinatorial RNAi Against HIV-1 Using Extended Short Hairpin RNAs. Liu YP, von Eije KJ, Schopman NC, Westerink JT, Brake OT, Haasnoot J, Berkhout B, Mol Ther 2009 17 1712 1723
50. RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice. Chen WZ, Yan WY, Du QY, Fei L, Liu MQ, Ni Z, Ni Z, Sheng ZT, Zheng ZX, J Virol 2004 78 6900 6907 (Pubitemid 38781528)
51. Cross-inhibition to heterologous footand-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome. Liu MQ, Chen WZ, Ni Z, Yan WY, Fei L, Jiao Y, Zhang J, Du QY, Wei XF, Chen JL, Liu YM, Zheng ZX, Virology 2005 336 51 59 (Pubitemid 40603670)
52. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo. Chen WZ, Liu MQ, Jiao Y, Yan WY, Wei XF, Chen JL, Fei L, Liu Y, Zuo XP, Yang FG, Lu YG, Zheng ZX, J Virol 2006 80 3559 3566
53. RNA interference effectively inhibits mRNA accumulation and protein expression of Hepatitis C Virus Core and E2 Genes inhuman cells. Liu M, Ding H, Zhao P, Qin ZL, Gao J, Cao MM, Luan J, Wu WB, Qi ZT, Biosci Biotechnol Biochem 2006 70 2049 2055 (Pubitemid 44451879)
54. Inhibition of hepatitis C virus replication and expression by small interfering RNA targeting host cellular genes. Xue Q, Ding H, Liu M, Zhao P, Gao J, Ren H, Liu Y, Qi ZT, Arch Virol 2006 152 955 962
55. Stably silencing of CD81 expression by small interfering RNAs targeting 3′-NTR inhibits HCV infection. Ding H, Liu Y, Bian ZQ, Wu WB, Zhao P, Qin ZL, Feitelson MA, Qi ZT, Hep Mon 2008 8 267 274
56. Inhibition of EGFP expression by siRNA in EGFP-stably expressing Huh-7 cells. Cao MM, Ren H, Pan X, Pan W, Qi ZT, J Virol Methods 2004 119 189 194 (Pubitemid 38670412)
57. PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma. Bian ZQ, Liu S, Liu MQ, Xiao A, Jiao Y, Yan WY, Zheng ZX, Zhong hua Yi Xue Za Zhi 2012 92 768 772
58. Association of heat shock protein 70 with lipid rafts is required for Japanese encephalitis virus infection in Huh7 cells. Zhu YZ, Cao MM, Wang WB, Wang W, Ren H, Zhao P, Qi ZT, J General Virol 2012 93 61 71
59. Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2. Li WH, Miao XH, Qi ZT, Zeng WT, Liang JX, Liang ZW, Virol J 2010 7 45 55
60. Efficient silencing of gene expression with modular trimeric Pol II expression cassettes comprising microRNA shuttles. Ely A, Naidoo T, Arbuthnot P, Nucleic Acids Res 2009 37 e91 1 10
61. Studies of cloned sequences from four Drosophila heat shock loci. Holmgren R, Livak K, Morimoto R, Freund R, Meselson M, Cell 1979 18 1359 1370 (Pubitemid 10172713)
62. Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics. DeFeel MR, Qin ZQ, Dai L, Isaacs JS, Parsons CH, Am J Cancer Res 2011 1 763 772
63. Recruitment of Hsp70 chaperones: a crucial part of viral survival strategies. Mayer MP, Rev Physiol Biochem Pharmacol 2005 153 1 46 (Pubitemid 44404353)
64. Heat shock cognate protein 70 is involved in rotavirus cell entry. Guerrero CA, Bouyssounade D, Zárate S, Isa P, López T, Espinosa R, Romero P, éndez E, López S, Arias CF, J Virol 2002 76 4096 4102 (Pubitemid 34250574)
65. 71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1. Sagara Y, Ishida C, Inoue Y, Shiraki H, Maeda Y, J Virol 1998 72 535 541 (Pubitemid 28048869)
66. GRP78, a coreceptor for coxsackievirus A9, interacts with major histocompatibility complex class I molecules which mediate virus internalization. Triantafilou K, Fradelizi D, Wilson K, Triantafilou M, J Virol 2002 76 633 643 (Pubitemid 34033362)
67. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. Reyes-del VJ, Chávez-Salinas S, Medina F, del Angel RM, J Virol 2005 79 4557 4567 (Pubitemid 40464207)
68. The virus-chaperone connection. Sullivan CS, Pipas JM, Virology 2001 287 1 8 (Pubitemid 32778232)
69. Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance. Wang YP, Zhao W, Xue R, Zhou ZX, Liu F, Han YX, Ren G, Peng ZG, Cen S, Chen HS, Li YH, Jiang JD, Antiviral Res 2011 89 227 231
70. Small molecular compounds that inhibit hepatitis C virus replication through destabilizing heat shock cognate 70 messenger RNA. Peng ZG, Fan B, Du NN, Wang YP, Gao LM, Li YH, Liu F, You XF, Han YX, Zhao ZY, Cen S, Li JR, Song DQ, Jiang JD, Hepatology 2010 52 845 853
71. Identification of hepatitis B virus genotypes in patients with chronic hepatitis B from different nationalities in ethnic minority areas in Yunnan Province, China. Bian ZQ, Hua ZL, Yan WY, Liu MQ, Zheng ZX, Zhonghua Yi Xue Za Zhi 2006 86 681 686
72. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Sells MA, Chen ML, Acs G, Proc Natl Acad Sci USA 1987 84 1005 1009 (Pubitemid 17031557)